3IRL | Carbohydrate | date | Aug 24, 2009 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Solution Structure Of Heparin Dp36 | ||||||||||||||
authors | S.Khan, J.Gor, B.Mulloy, S.J.Perkins | ||||||||||||||
compound | source | ||||||||||||||
Molecule: 2-O-Sulfo-Alpha-L-Idopyranuronic Acid-(1-4)-2-Deo Sulfo-2-(Sulfoamino)-Alpha-D-Glucopyranose-(1-4)-2-O-Sulfo- Idopyranuronic Acid-(1-4)-2-Deoxy-6-O-Sulfo-2-(Sulfoamino)- Glucopyranose-(1-4)-2-O-Sulfo-Alpha-L-Idopyranuronic Acid-( Deoxy-6-O-Sulfo-2-(Sulfoamino)-Alpha-D-Glucopyranose-(1-4)- Alpha-L-Idopyranuronic Acid-(1-4)-2-Deoxy-6-O-Sulfo-2-(Sulf Alpha-D-Glucopyranose-(1-4)-2-O-Sulfo-Alpha-L-Idopyranuroni 4)-2-Deoxy-6-O-Sulfo-2-(Sulfoamino)-Alpha-D-Glucopyranose-( Sulfo-Alpha-L-Idopyranuronic Acid-(1-4)-2-Deoxy-6-O-Sulfo-2 (Sulfoamino)-Alpha-D-Glucopyranose-(1-4)-2-O-Sulfo-Alpha-L- Idopyranuronic Acid-(1-4)-2-Deoxy-6-O-Sulfo-2-(Sulfoamino)- Glucopyranose-(1-4)-2-O-Sulfo-Alpha-L-Idopyranuronic Acid-( Deoxy-6-O-Sulfo-2-(Sulfoamino)-Alpha-D-Glucopyranose-(1-4)- Alpha-L-Idopyranuronic Acid-(1-4)-2-Deoxy-6-O-Sulfo-2-(Sulf Alpha-D-Glucopyranose-(1-4)-2-O-Sulfo-Alpha-L-Idopyranuroni 4)-2-Deoxy-6-O-Sulfo-2-(Sulfoamino)-Alpha-D-Glucopyranose-( Sulfo-Alpha-L-Idopyranuronic Acid-(1-4)-2-Deoxy-6-O-Sulfo-2 (Sulfoamino)-Alpha-D-Glucopyranose-(1-4)-2-O-Sulfo-Alpha-L- Idopyranuronic Acid-(1-4)-2-Deoxy-6-O-Sulfo-2-(Sulfoamino)- Glucopyranose-(1-4)-2-O-Sulfo-Alpha-L-Idopyranuronic Acid-( Deoxy-6-O-Sulfo-2-(Sulfoamino)-Alpha-D-Glucopyranose-(1-4)- Alpha-L-Idopyranuronic Acid-(1-4)-2-Deoxy-6-O-Sulfo-2-(Sulf Alpha-D-Glucopyranose-(1-4)-2-O-Sulfo-Alpha-L-Idopyranuroni 4)-2-Deoxy-6-O-Sulfo-2-(Sulfoamino)-Alpha-D-Glucopyranose-( Sulfo-Alpha-L-Idopyranuronic Acid-(1-4)-2-Deoxy-6-O-Sulfo-2 (Sulfoamino)-Alpha-D-Glucopyranose-(1-4)-2-O-Sulfo-Alpha-L- Idopyranuronic Acid-(1-4)-2-Deoxy-6-O-Sulfo-2-(Sulfoamino)- Glucopyranose-(1-4)-2-O-Sulfo-Alpha-L-Idopyranuronic Acid-( Deoxy-6-O-Sulfo-2-(Sulfoamino)-Alpha-D-Glucopyranose; Chain: A Engineered: Yes |
|||||||||||||||
symmetry | Space Group: P 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | Solution Scattering | resolution | |||||||||||||
ligand | IDS, SGN | enzyme |
| ||||||||||||
Primary reference | Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes., Khan S, Gor J, Mulloy B, Perkins SJ, J Mol Biol. 2010 Jan 22;395(3):504-21. Epub 2009 Nov 3. PMID:19895822 |
Data retrieval |
View 3IRL in 3D |
Visual 3D analysis of 3IRL |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3IRL |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |